IPSC vs PAYC · rev $6.6M vs P/E 33, rev $1.88B
Century Therapeutics Inc (IPSC) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported PAYC revenue for 2024-12-31 was $1.88B. Net income was $502.0M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
IPSC currently screens at market cap $47.8M. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the IPSC and PAYC stock pages for the full models.
Not investment advice.